| Attribute |
Value |
| 52 Week Change |
-0.75559324 |
| Address1 |
885 West Georgia Street |
| Address2 |
Suite 1445 |
| All Time High |
32,175.0 |
| All Time Low |
0.575 |
| Ask |
0.9207 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
36,830 |
| Average Daily Volume3 Month |
107,493 |
| Average Volume |
107,493 |
| Average Volume10Days |
36,830 |
| Beta |
0.519 |
| Bid |
0.504 |
| Bid Size |
2 |
| Book Value |
3.419 |
| City |
Vancouver |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
Canada |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.7213 |
| Current Ratio |
5.938 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,774,915,200 |
| Day High |
0.7494 |
| Day Low |
0.7083 |
| Debt To Equity |
5.548 |
| Display Name |
InMed Pharmaceuticals |
| Dividend Date |
1,593,993,600 |
| Earnings Timestamp End |
1,778,616,000 |
| Earnings Timestamp Start |
1,778,616,000 |
| Ebitda |
-7,630,413 |
| Ebitda Margins |
-1.6931701 |
| Enterprise To Ebitda |
0.571 |
| Enterprise To Revenue |
-0.967 |
| Enterprise Value |
-4,359,951 |
| Eps Forward |
-6.25 |
| Eps Trailing Twelve Months |
-2.88 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fax |
778 945 6800 |
| Fifty Day Average |
0.792 |
| Fifty Day Average Change |
-0.07069999 |
| Fifty Day Average Change Percent |
-0.08926766 |
| Fifty Two Week Change Percent |
-75.559326 |
| Fifty Two Week High |
7.98 |
| Fifty Two Week High Change |
-7.2587 |
| Fifty Two Week High Change Percent |
-0.9096115 |
| Fifty Two Week Low |
0.575 |
| Fifty Two Week Low Change |
0.14630002 |
| Fifty Two Week Low Change Percent |
0.25443482 |
| Fifty Two Week Range |
0.575 - 7.98 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,399,296,600,000 |
| Float Shares |
2,163,905 |
| Forward Eps |
-6.25 |
| Forward P E |
-0.115408 |
| Free Cashflow |
-4,306,249 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
13 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.29726 |
| Gross Profits |
1,339,632 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00124 |
| Held Percent Institutions |
0.09276 |
| Implied Shares Outstanding |
3,314,063 |
| Industry |
Drug Manufacturers - Specialty & Generic |
| Industry Disp |
Drug Manufacturers - Specialty & Generic |
| Industry Key |
drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,751,241,600 |
| Last Split Date |
1,731,542,400 |
| Last Split Factor |
1:20 |
| Long Business Summary |
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with unmet medical needs. The company's lead product consists of INM-755, a cannabinol topical skin cream that has completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-089, a small molecule compound that acts as a selective dual CB1/CB2 agonist; and INM-900 for neurodegenerative diseases, as well as INM-901, a small molecule for treatment of Alzheimer's disease. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada. |
| Long Name |
InMed Pharmaceuticals Inc. |
| Market |
us_market |
| Market Cap |
2,390,433 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_9199217 |
| Most Recent Quarter |
1,767,139,200 |
| Net Income To Common |
-7,664,363 |
| Next Fiscal Year End |
1,782,777,600 |
| Non Diluted Market Cap |
2,483,558 |
| Open |
0.7222 |
| Operating Cashflow |
-7,421,862 |
| Operating Margins |
-2.5856698 |
| Payout Ratio |
0.0 |
| Phone |
604 669 7207 |
| Pre Market Change |
-0.027400017 |
| Pre Market Change Percent |
-3.7986991 |
| Pre Market Price |
0.6939 |
| Pre Market Time |
1,776,844,816 |
| Previous Close |
0.7231 |
| Price Hint |
4 |
| Price To Book |
0.21096812 |
| Price To Sales Trailing12 Months |
0.5304297 |
| Profit Margins |
-1.7007 |
| Quick Ratio |
4.852 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.0018000007 |
| Regular Market Change Percent |
-0.24892832 |
| Regular Market Day High |
0.7494 |
| Regular Market Day Low |
0.7083 |
| Regular Market Day Range |
0.7083 - 0.7494 |
| Regular Market Open |
0.7222 |
| Regular Market Previous Close |
0.7231 |
| Regular Market Price |
0.7213 |
| Regular Market Time |
1,776,801,600 |
| Regular Market Volume |
13,727 |
| Return On Assets |
-0.49773997 |
| Return On Equity |
-0.97203004 |
| Revenue Growth |
-0.262 |
| Revenue Per Share |
1.718 |
| Sand P52 Week Change |
0.3140242 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
3,314,063 |
| Shares Percent Shares Out |
0.0315 |
| Shares Short |
92,063 |
| Shares Short Previous Month Date |
1,772,150,400 |
| Shares Short Prior Month |
91,422 |
| Short Name |
InMed Pharmaceuticals Inc. |
| Short Percent Of Float |
0.0318 |
| Short Ratio |
0.43 |
| Source Interval |
15 |
| State |
BC |
| Symbol |
INM |
| Total Cash |
6,997,509 |
| Total Cash Per Share |
2.397 |
| Total Debt |
531,949 |
| Total Revenue |
4,506,597 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-2.88 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
1.59375 |
| Two Hundred Day Average Change |
-0.87245 |
| Two Hundred Day Average Change Percent |
-0.5474196 |
| Type Disp |
Equity |
| Volume |
13,727 |
| Website |
https://www.inmedpharma.com |
| Zip |
V6C 3E8 |